In the past decade, in vitro evolution techniques have been used to improve the performance or alter the activity of a number of different enzymes and have generated enzymes de novo. In this review, we provide an overview of the available in vitro methods, their application, and some general considerations for enzyme engineering in vitro. We discuss the advantages of in vitro over in vivo approaches and focus on ribosome display, mRNA display, DNA display technologies, and in vitro compartmentalization (IVC) methods. This review aims to help researchers determine which approach is best suited for their own experimental needs and to highlight that in vitro methods offer a promising route for enzyme engineering.
In vitro enzyme evolution offers a means to engineer enzymes by exploring enormous libraries of protein variants that exceed the capabilities of in vivo methods. The development of cell-free protein production systems made it possible to evolve enzymes outside of cells, in a test tube. In vitro evolution techniques have been used to improve existing enzymes and, in addition, have enabled the generation of biocatalysts de novo from a non-catalytic protein library.
All methods used for enzyme evolution require that each protein in a pool of mutants can be traced back to its encoding gene for identi fi cation, and potentially for the purpose of ampli fi cation, expression, and further evolution ( 1 ) . A stable genotype-phenotype linkage allows for many enzyme variants to be mixed in a single reservoir while maintaining the ability to amplify genes of individual desired variants. Those variants are isolated from the reservoir using suitable screening or selection approaches. In the case of in vivo evolution methods, the genotype and phenotype are linked as the protein and its gene are contained in the same cell. With partial in vitro methods, proteins are translated by the host's cellular machinery and then displayed in an extracellular fashion, for example, on the surface of a phage in the phage display approach. In contrast, the methods described in this review are carried out entirely in vitro and do not require any step to be performed inside a host cell. The crucial genotype-phenotype link is maintained through either a direct physical link or through arti fi cial compartmentalization. This review will discuss in vitro enzyme evolution technologies such as ribosome display, mRNA display, in vitro compartmentalization (IVC), and different versions of DNA display ( Fig. 1 ). We will focus on protein enzymes only and therefore exclude the work on in vitro evolution of ribozymes and deoxyribozymes ( 2, 3 ) . We will fi rst describe general features common to all in vitro protein evolution strategies and then review the individual methods in more detail, highlighting examples of enzymes that have been evolved. We will also include several in vitro evolution strategies that have so far only been used for proof-of-principle model selections. We believe that this overview and the number of general considerations presented here will provide the reader with suf fi cient information to decide which of these broadly applicable in vitro techniques may be best suited for their own research. We hope to encourage scientists to harness the advantages of in vitro methods to evolve their speci fi c enzyme of interest. In vitro methodologies have several advantages over in vivo and partial in vitro methods because they are not limited by cell survival, growth, or function. The three main advantages are (1) the ability to work with larger libraries of variants, (2) the tolerance to conditions that would be deleterious to cell survival, and (3) the ability to directly manipulate the DNA after each round of evolution.
As in vitro evolution is not dependent on library transformation into a host, the number of unique sequences that can be evaluated in a single experiment exceeds in vivo approaches. The largest reported in vitro libraries contain 10 14 DNA sequences ( 4 ) . By comparison, phage display libraries produce up to 10 10 unique variants in a single transformation ( 5 ) . Library sizes up to 10 12 variants were reported for phage display by the pooling of dozens of separate transformations, but such scale-up may not be feasible for most laboratories ( 6 ) . Most typical library sizes for in vivo selections are between 10 6 and 10 8 variants. Because in vitro evolution can search a larger sequence space, it is particularly well suited for isolating bene fi cial enzyme mutations that may be very rare.
The evolution of enzymes in vitro greatly expands the range of substrates and environmental conditions that can be investigated. The presentation of substrate to the enzymes is simpli fi ed as no cell walls have to be crossed, which are impermeable to many potential substrates. Most importantly, substrates and enzymes can be used that would be toxic to a cell ( 7 ) . Furthermore, enzymes can be engineered with in vitro methods for increased stability under extreme conditions of pH, temperature, ion concentration, or in the presence of denaturants or organic solvents. In vitro evolution also allows for a more accurate representation of enzyme performance. Cellular evolution, in contrast, can generate complex phenotypes that falsely suggest increased activity through increased enzyme accumulation, rather than improved catalysis ( 8 ) .
Finally, in vitro evolution allows for direct manipulation of the DNA library between each round of evolution. Unlike in vivo methods that require time-consuming puri fi cation of the target gene, DNA from in vitro evolution is ampli fi ed directly through PCR. This facilitates the introduction of diversity through methods like error-prone PCR or in vitro recombination. In comparison, in vivo methods may introduce genetic diversity by using microbial strains de fi cient in DNA repair pathways to eliminate the need for DNA puri fi cation. However, these mutations may occur anywhere in the genome, necessitating a low mutation rate for continued survival ( 9 ) . Thus, by combining a selection or screen with methods to add genetic diversity, full Darwinian evolution can be carried out more conveniently in vitro.
Bene fi ts of In Vitro Evolution
While in vitro evolution greatly expands the tools available for the creation and engineering of new enzymes, in vivo approaches have certain advantages, too. As in vitro methods require puri fi cation of the genotype-phenotype components, in vivo evolution may involve fewer discrete steps. Furthermore, some enzymes are being developed for in vivo use, such as enzymes that need to function within a metabolic pathway. Those enzymes could initially be evolved in vitro, but ultimately need to be evolved in their native environment to optimize their intracellular compatibility. Thus, the two approaches can complement each other.
All in vitro directed evolution methods follow a similar scheme. The initial DNA library encoding the protein variants is transcribed and translated, either sequentially or in a one-pot reaction. Next, the genotype-phenotype link and then genotype-phenotype-substrate link is established. This may be accomplished through a physical connection (ribosome display, mRNA display, and DNA display), or through compartmentalization (IVC, IVC-based DNA, and microbead displays) (Fig. 1 ) . Active enzyme variants that convert substrate to product result in co-localization of genotype-phenotype with product and are then isolated by screening or selection. Finally, the genotype is recovered and either analyzed directly by sequencing or subjected to additional diversi fi cation for subsequent rounds of evolution. In the following sections, we will brie fl y discuss aspects of the construction of DNA libraries, present the different in vitro methods individually, and discuss their application for enzyme engineering.
In any directed evolution procedure, the size and quality of the starting DNA library are of great importance as they affect the probability of fi nding the desired mutant. Numerous reviews are available to guide researchers through library design and construction (27) (28) (29) (30) (31) . Here, we will highlight only a few general considerations and point out aspects speci fi c to in vitro evolution methods.
Although in vitro selection methods can sift through comparably large libraries of trillions of mutants, the sheer size of the protein sequence space prevents us from sampling more than an exceedingly small fraction of all possibilities. For example, the largest 3. General Work fl ow for In Vitro Methods
Library Construction
protein libraries used to date contain about 10 13 variants (Table 1 ). This vast number of mutants will just be enough to include one molecule of all possible combinations for a sequence of ten amino acid positions. In comparison, most natural proteins are more than 100 amino acids in length. Therefore, libraries of mutants should be designed wisely to increase the chances of success in a directed evolution experiment. Accordingly, one should consider randomizing speci fi c amino acid positions by using degenerate codons. Instead of randomizing positions with NNN codons (N = A,C,G,T), NNK codons (K = G,T), NNS codons (S = C,G) or even a reduced alphabet of NDT codons (D = A,G,T) can be used to reduce oversampling caused by codon degeneracy ( 32 ) . The use of degenerate codons can also reduce the likelihood of introducing unintended stop codons. For example, the NNN codon includes three stop codons, whereas the NNK or NNS codons include only one. Alternatively, a given library can be assembled from fragments that have been preselected to decrease the occurrence of premature stop codons ( 4 ) . More recently, DNA synthesis via phosphoramidite trinucleotides has become commercially available ( 33 ) . Codon by codon synthesis using trinucleotides offers full control of the library composition by de fi ning the set of desired amino acid mutations at any position while avoiding stop codons (see Note 1). This method is still costly but will likely become affordable in the near future ( 34 ) .
In order to use a DNA library for a speci fi c in vitro evolution technique, the sequences at both termini of the DNA have to be made compatible to the method of choice. The 5 ¢ -end includes promoter and enhancer sequences necessary to facilitate transcription and translation, respectively (see Note 2) . The nature of these sequences depends on the type of transcription and translation system used (see Note 3). Other sequence elements might be included such as a terminator, stabilizing hairpins, af fi nity puri fi cation tags, or sequences that are speci fi c to the particular in vitro evolution method ( 35 ) (see Note 4).
Ribosome display . The ribosome display technology creates the genotype-phenotype linkage through a ternary complex of a stalled ribosome, the translated protein and its encoding mRNA (Fig. 1 ) . The complex is stabilized by high magnesium concentrations and low temperatures. Ribosome display was initially described for the puri fi cation of speci fi c mRNA sequences based on immunoprecipitation of the encoded protein ( 36 ) . Subsequently, this method was developed further to select and evolve peptides and proteins ( 37, 38 ) . Although ribosome display has mostly been used for selection Table 1 Comparison of in vitro technologies discussed in this review Method Genotype-phenotype link
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Reported variants in single experiment
Results
Ribosome display
Non-covalent complex of mRNA-ribosome-protein
Proof-of-concept selections for sialyltransferase ( 10 ) , beta-lactamase ( 11 ) , dihydrofolate reductase ( 12 ) , DNA ligase ( 13 ) , and sortase ( 14 ) mRNA display Proof-of-concept selection of binders, but no enzymes ( 17, 18 ) In vitro compartmentalization (IVC)
Spatial con fi nement Selection of antibodies as heterodimers, but no enzymes ( 26 ) of binders, several model selections for enzymatic activity have been reported and will be reviewed here in more detail. Several criteria must be met in order to generate ribosomedisplayed proteins. Most importantly, the terminal stop codon of the gene of interest must be removed. This will prevent the ribosome from dissociating and releasing the nascent protein and will instead promote stalling of the ribosome and therefore maintain the ternary complex. Stem-loop structures are often added to fl ank the gene on both termini to increase RNA stability during translation and subsequent manipulations. Since the protein is not released from the ribosome, a C-terminal protein spacer (>100 amino acids) is added to ensure that the displayed protein has exited the proteinconducting channel of the ribosome and can fold properly. Typically, ribosome-displayed proteins are generated through sequential transcription and translation, as coupled transcription/ translation systems can result in 100-fold reduced protein yield ( 38, 39 ) . The translation is stopped by decreasing the temperature and increasing the Mg 2+ concentration to stabilize the ternary complex. To maintain the genotype-phenotype linkage, the subsequent selection process also has to be performed at low temperatures and in presence of elevated Mg 2+ concentrations. The ribosome-displayed proteins are mostly used in selections without any additional puri fi cation. The RNA is recovered after the selection by dissociating the ternary complex through chelation of Mg 2+ with EDTA. A detailed protocol has been published elsewhere ( 40 ) (see Note 5) .
Ribosome display has been utilized in a number of model selections for enzymatic activity. Most selections were performed by selecting for binding to an immobilized substrate, substrate analog, or inhibitor. These model selections demonstrated enrichment of the desired enzyme (10-to 100-fold per round of selection) compared to an inactive control (Table 1 ) (10) (11) (12) 14 ) . While enzyme selection strategies based on binding can be successful in isolating enzymes with known properties (e.g., searching through metagenomic libraries for a desired activity), they are not well suited for changing substrate speci fi city or substantially improving activity ( 41, 42 ) . In one example of a truly product-driven model selection, ribosome display has been employed for isolation of a T4 DNA ligase ( 13 ) . Active enzymes able to ligate a DNA adaptor to the 3 ¢ -end of their encoding mRNA were selectively ampli fi ed via an adaptor-speci fi c primer and were enriched 40-fold over known inactive mutants. Similar to this selection approach, the 3 ¢ -end of the mRNA could be used for the attachment of alternative substrates which would allow for a selection of other catalysts by ribosome display.
mRNA display . mRNA-displayed proteins are covalently attached to their encoding mRNA via the small linker molecule puromycin ( Fig. 1 ) ( 43, 44 ) . This stable covalent link allows for the selection of proteins under a wide range of conditions. mRNA display has been used to select for a novel enzymatic activity from a non-catalytic library of randomized proteins ( 15, 16 ) . This is the fi rst example of a de novo enzyme generated by directed evolution from a naïve library. In addition, and similar to ribosome display, mRNA display has been widely employed for isolation of binders ( 45 ) .
Central to the mRNA display method is the modi fi cation of the stop codon-free 3 ¢ -end of the messenger RNA with a puromycin-containing DNA linker prior to translation ( 46, 47 ) . During the subsequent in vitro translation, the ribosome synthesizes the polypeptide until it reaches the DNA-puromycin-modi fi ed 3 ¢ -end of the mRNA where it stalls. Puromycin, which is an antibiotic that mimics the aminoacyl end of tRNA, enters the ribosome and becomes covalently attached to the C-terminus of the nascent polypeptide. The resulting mRNA-displayed proteins are typically puri fi ed from unfused proteins and mRNA using puri fi cation tags. The mRNA-displayed proteins are reverse transcribed to produce the cDNA. Reverse transcription also minimizes potential RNA secondary structure and increases RNA stability. Detailed protocols on mRNA display have been published recently ( 16, 48, 49 ) . Through slight modi fi cations of the mRNA display protocol, covalent fusions of protein and encoding cDNA can be generated (cDNA display) ( 50, 51 ) .
mRNA display is the fi rst directed evolution method that has produced an entirely arti fi cial enzyme without a predecessor in nature. Starting from a non-catalytic protein scaffold containing two zinc fi ngers with each loop randomized ( 52 ) , the authors isolated an RNA ligase enzyme that catalyzes the splinted ligation of a 5 ¢ -triphosphorylated RNA strand to the 3 ¢ -hydroxyl end of a second RNA ( 15, 16 ) . This particular catalytic activity has not been reported in any natural enzyme. For this selection, product formation was the only selection criterion. The authors attached one of the substrates to the mRNA-displayed protein during the reverse transcription step forming a protein-mRNA-cDNA-substrate complex. The incubation with the second substrate, which was labeled with biotin, allowed any active enzymes to ligate the biotin moiety to their own cDNA enabling the selective immobilization on streptavidin beads. The isolated enzyme accelerates the reaction more than 10
In vitro compartmentalization (IVC) . Directed evolution by IVC mimics in vivo evolution inside a cell by using water-in-oil emulsions to enclose proteins and their encoding DNA within the same droplet compartment thereby creating the genotype-phenotype link through spatial con fi nement ( 54 ) . IVC has been employed not only in several model enzyme selections, but also to improve the performance of existing enzymes through screening and selection methods.
Compartmentalization by droplet formation is achieved by stirring an aqueous solution of genes and a coupled transcription/ translation (TS/TL) system into a mixture of mineral oil and surfactants ( 55 ) . The DNA concentration is chosen such that the average droplet contains no more than a single gene. The low volume of the droplets (5-10 femtoliters) corresponds to a low nanomolar concentration of the single DNA molecule, which is ef fi ciently transcribed and translated inside the droplet ( 22, 54, 56 ) . Although droplet composition is similar across different IVC experiments, in some cases the oil/surfactant mixtures need to be optimized for compatibility with the speci fi c TS/TL solution used and the enzymatic activity that is being evolved ( 54, 57 ) . It has been shown that the droplets are stable up to 100 °C for many days and do not exchange DNA or protein between each other ( 54, 58 ) . Detailed protocols for the IVC method have been published ( 55 ) .
IVC-based selections have been used to evolve enzymes that process nucleic acid substrates. Here, the encoding DNA is also the substrate for the enzyme and the selection is dependent on successful DNA modi fi cation. In one approach, the activity of the methyltransferase (M.HaeIII) was improved toward a nonnative, although already recognized, DNA sequence ( 19 ) . A library of variants of M.HaeIII was made by mutating the DNA contacting residues. The 3 ¢ -end of the DNA library was modi fi ed with a biotin moiety and connected to the remaining gene via the target methylation site that can be cleaved by endonuclease NheI unless the site is has been methylated by M.HaeIII. Therefore, only methylated genes were not cleaved by NheI and were captured on streptavidin beads. A similar approach was used for the model selection of a restriction endonuclease activity from a randomized library of the restriction enzyme FokI. Three speci fi c residues were randomized in the catalytic domain, and cleavage sites for FokI were introduced in the 3 ¢ -UTR ( 20 ) . Only the genes coding for an active FokI variant were cleaved and captured on beads after incorporation of biotinylated deoxyuracil triphosphate at the cohesive ends generated by the restriction enzyme.
The IVC methodology has also been used in combination with screening approaches. This allows for the evolution of enzymes for non-nucleic acid-related reactions, but also reduces the number of mutants that can be interrogated compared to selection strategies. In the screening approach, either fl uorescence-activated cell sorting (FACS) or micro fl uidics-based droplet sorting is used to separate active and inactive enzymes based on the conversion of nonfl uorescent substrate into fl uorescent product. For FACS mediated screening, water-in-oil-in-water emulsions (double emulsions) are generated since FACS instrumentation is incompatible with oil as the main medium ( 59 ) . Exploiting this principle, the very low b -galactosidase activity of the Ebg enzyme from Escherichia coli was increased at least 300-fold by in vitro evolution using a commercially available fl uorogenic substrate ( 22 ) . Recently, the same researchers reported a model enrichment of b -galactosidase using a homemade micro fl uidic system ( 21 ) . Although the throughput in the micro fl uidic system is about tenfold less than in FACS-based screening, this loss is offset by other advantages. First, the micro fl uidic system generates highly monodisperse droplets, enabling quantitative kinetic analysis ( 21, 60 ) . Second, the authors utilized micro fl uidic components that allowed them to fuse droplets together and introduce new content into droplets. This conferred multiple bene fi ts as the authors were able to perform emulsion PCR in droplets and then merge them with droplets containing the TS/TL mix. By generating about 30,000 gene copies per droplet prior to TS/TL, low enzymatic activity is more likely to be detected due to the elevated enzyme concentration ( 21 ) . Furthermore, reagents can be readily added to the droplets after translation, in case the translation conditions are not compatible with enzymatic assay ( 61 ) . The use of micro fl uidics is a promising route for IVC-based enzyme engineering due to the modularity and potential for customization of individual components. However, in contrast to commercially available FACS instruments, assembly of micro fl uidics devices still requires substantial expertise.
IVC has also been used in conjunction with in vivo enzyme evolution by generating compartments that contain cells. To keep the focus of this review we are not discussing this in vivo application.
DNA display . Strategies that either directly or indirectly establish a physical link between the DNA and the encoded protein are referred to as DNA display (Table 2 ) . Although several different DNA display methods have been developed, only the IVC-mediated microbead display has been used to evolve enzymes. This method generates the genotype-phenotype link through the capture of DNA and its translated protein onto the same streptavidin-coated microbeads inside a droplet (Fig. 1 ) ( 23, 24 ) . This approach requires multiple biotinylated reagents such as primers, antibody, and reaction substrate in order to capture the template DNA, the protein modi fi ed with an epitope tag and the substrate onto the microbead, respectively.
Using microbead display, Taw fi k and Grif fi ths improved the catalytic performance of an already very ef fi cient phosphotriesterase enzyme 63-fold ( k cat > 10 5 s −1
) through FACS-based screening ( 23 ) .
This work demonstrated the ability to generate, break, and regenerate the IVC droplets and purify the genotype-phenotype product attached to the microbeads. Furthermore, a substrate was used that carried a photo-caged biotin. Therefore, the substrate stays in solution until the biotin is uncaged, which causes the immobilization of substrate and resulting product on the beads. Incubation with a fl uorescent product-speci fi c antibody enabled the speci fi c labeling and isolation by FACS of only those microbeads to which functional enzymes and their coding DNA were attached ( 23 ) .
In a different proof-of-concept experiment, a modi fi ed microbead display protocol was performed as a selection instead of a screen, thereby potentially harnessing larger library sizes ( 25 ) . In this experiment, an active biotin ligase was enriched from a mixture of inactive genes. Following product formation and immobilization, the puri fi ed microbeads were incubated with product-speci fi c antibodies that were conjugated to a cleavable, gene-speci fi c PCR primer instead of a fl uorophore. Re-emulsi fi cation and droplet PCR with a solution lacking this primer resulted in a 20-fold enrichment of the desired genes.
Another microbead display model screen employing FACS used an indirect readout for activity to isolate (FeFe) hydrogenases ( 24 ) . Because the hydrogenase activity (H 2 breakdown) is dif fi cult to measure directly, the authors employed a redox-sensitive dye that can generate a fl uorescent signal. Puri fi ed microbeads carrying the immobilized DNA and enzymes were re-compartmentalized in the presence of the redox dye. This dye was modi fi ed with a C12-alkyl chain and therefore interacts nonspeci fi cally with the hydrophobic polystyrene beads. Hydrogenase activity resulted in fl uorescence of the dye and enabled fl ow cytometric sorting of the microbeads to recover the DNA of active enzymes, yielding a 20-fold enrichment over inactive genes. This proof-of-concept study used micro fl uidics to generate monodisperse droplets and microbeads with a larger diameter (5.6 m m rather than 1 m m) to increase the bead surface allowing more fl uorescent substrate to bind, thereby improving the signal to noise ratio. The indirect readout as described here could be applied to other screening strategies if environmentally sensitive fl uorophores are available (pH, redox potential). Presently, only microbead display has been employed to evolve enzymes. Yet other DNA display methods could potentially be used for this purpose. In contrast to microbead display, all other DNA display methods directly attach the protein to its encoding gene via a fusion protein which binds to a speci fi c DNA sequence within the parent gene or to a small molecule attached to the parent gene ( Table 2 ). The IVC method is often used in conjunction with DNA display as the physical genotype-phenotype linkage allows for the microcompartments to be broken up and generated again in order to introduce new components into the system (e.g., substrates). However, two proof-of-concept studies conducted without IVC demonstrated the production of DNA-displayed proteins solely by incubating templates with the E . coli cell extract ( 17, 18 ) .
In the previous section, we highlighted individual examples for the use of in vitro enzyme evolution. In this section, we will compare the different methods and discuss aspects that several methods have in common.
The types of reactions catalyzed by enzymes can be divided into transformation reactions, bond-forming reactions, and bond-breaking reactions (Fig. 2a ) . Depending on the reaction type, the strategy by which enzymes can be selected varies slightly. In general, af fi nity selections are used to isolate enzymes by methods that create a physical link between phenotype and genotype such as ribosome display, mRNA display, and DNA display (Figs. 1 and 2b ) . To enable an enzyme af fi nity selection, the substrate has to be linked to the gene-enzyme complex. Enzymes for a transformation reaction can then be isolated if a product-speci fi c af fi nity reagent, such as an antibody, is available (reaction type 1). Via the antibody, the ternary complex of product, active enzyme, and gene is separated from inactive variants through immobilization (see Note 6) . In the case of an af fi nity selection for bond-forming enzymes (reaction type 2), the second substrate carries a selectable moiety. Only proteins that catalyze the bond formation between two substrates will attach this moiety to the gene-protein-substrate complex and can therefore be isolated. For bond-breaking reactions (reaction type 3), the whole complex of gene, protein, and substrate is immobilized via the substrate and only variants that cleave the bond will be released and selected (see Note 7) . In contrast to af fi nity selections, the IVC methodology mostly employs fl uorescent screening to isolate evolved enzyme variants either by FACS or micro fl uidics (Fig. 2c,  d ). This can be achieved if the product of the reaction becomes fl uorescent or a fl uorescent product-speci fi c antibody is available. Alternatively, the second substrate, which will be attached in a bond-forming reaction to the gene-microbead-substrate complex, is fl uorescent.
General Principles and Comparison of Different Methods
For any enzyme evolution experiment regardless of which methodology is used, the speci fi c selection or screening strategy has to be customized with respect to the underlying reaction. In the case of af fi nity selections, the need to link the substrate to the gene complex without substantially changing the nature of the substrate can be challenging especially for small substrates (see . On the other hand, suitable fl uorophores that enable the screening of IVC droplets might not be compatible with some types of chemical reactions.
Two important questions have to be considered when deciding on which enzyme evolution strategy to use: Is the desired mutant potentially very rare such as a mutant exhibiting a novel activity? Or, alternatively, is the goal of the evolution experiment to generate a highly pro fi cient enzyme? Selection strategies can search larger libraries and are therefore more likely to discover rare mutants, compared to screening approaches. At the same time, af fi nity selections only select for a single turnover event and cannot evolve an enzyme for high substrate af fi nity as the substrate is linked to the enzyme and therefore present at a high local concentration. In contrast, IVC-based screening methods can directly evolve an enzyme for high turnover and substrate af fi nity, yet, the library size of screening methods is several orders of magnitude smaller than those of selections. Therefore, it might be most bene fi cial to combine the two strategies and fi rst use an af fi nity selection method to isolate potentially rare enzyme variants with altered activity or substrate speci fi city and then switch to an IVC-based screening method to optimize enzymatic pro fi ciency.
Enzyme engineering by in vitro enzyme evolution has made tremendous progress in the past decade. We now have a range of powerful in vitro methods available that can ef fi ciently evolve biocatalysts in a test tube by searching protein libraries orders of magnitude larger than those used by conventional in vivo evolution approaches. In vitro enzyme evolution is uniquely suited to address two of the greatest challenges in biocatalyst design: de novo generation of novel activity and activity within harsh environments. Applying the repertoire of in vitro evolution methods, exciting new examples of enzyme engineering are expected to emerge, thereby solving problems in biocatalysis that have previously been dif fi cult to address.
1. Codon usage and compatibility . Depending on the translation system used, the codon usage can vary substantially. During library construction, it is important to try to avoid rare codons that would reduce the translation yield. Furthermore, enzymes evolved using eukaryotic systems (e.g., rabbit reticulocyte) might employ codons that cause dif fi culty with protein expression and evolution in prokaryotes, requiring the use of strains that supplement rare/eukaryotic tRNAs.
2.
Increasing in vitro translation yields . Translation can be controlled or improved by enhancer sequences such as a ribosome binding site for E . coli -based cell-free extracts ( 19 ) , by an AMV enhancer for eukaryotic systems, or a TMV translation enhancer for both eukaryotic systems and E . coli -based systems ( 67 ) . Furthermore, the optimization of translation conditions (lysate, salt, and template concentrations) can also increase the protein yield.
3. Translation systems . Several commercial and homemade options are available for in vitro protein translation such as E . coli , rabbit reticulocyte, and wheat germ lysates. E . coli translation systems are attractive because of their low cost and high protein production but suffer from abundant nuclease contamination and simple folding machinery. Rabbit reticulocyte lysates conversely are expensive but robust in promoting proper folding and contain fewer nucleases. Wheat germ lysate provides an intermediate between rabbit reticulocyte and E . coli extracts in that it is both inexpensive and promotes folding, but it requires fi ne optimization of ionic concentrations for each gene.
Conclusions
Notes
Minimal reconstituted systems of puri fi ed individual components (e.g., commercially available PURE kits) have also been employed and have been shown to improve stability and ef fi ciency of mRNA-based methods ( 68 ) . Such systems are also more amenable to unnatural amino acid incorporation. Ultimately, the nature of the in vitro method and the enzyme of interest dictate the type of lysate that might be best suited for the desired application. For review articles see ref. 69-71 . 4 . UTR reconstitution between rounds of evolution . The 5 ¢ -UTR, and in some cases 3 ¢ -UTR ( 20 ) , are lost during transcription and translation and need to be reconstituted before a subsequent round. This can be done by PCR ( 15 ) , overlap extension PCR ( 20 ) , or by a coupled uracil excision-ligation strategy ( 72 ) .
5. Ribosome display variations . Several modi fi cations to the ribosome display technology can increase the stability of the ternary complex and were recently highlighted in Methods in Molecular Biology ( 73 ) . Ribosome-inactivation display (RID) utilizes a ricin toxin to inactivate and stall the ribosome, resulting in covalent attachment of protein to the ribosome. Although use of the ricin toxin substantially increases the total gene size by about 1 kb, the ribosomes no longer need to be kept at low temperature and high salt concentrations to maintain the genotype-phenotype link ( 74 ) . Alternatively, the use of translation mixtures assembled from puri fi ed components ( 68 ) or depleted of transfer-messenger RNA (tmRNA) ( 38 ) have also been used to increase yield and stability of the ternary complex by eliminating stalled ribosome rescue mechanisms.
Minimizing nonspeci fi c interactions during immobilization .
Attachment of large biopolymers to the enzyme of interest (e.g., DNA-, RNA-, or ribosome display) may result in nonspeci fi c interaction with the resins used during immobilization and puri fi cation, lowering the overall enrichment of the desired enzymes. With the exception of pure IVC and mRNA display, all in vitro methods require use of fusion proteins, further increasing size of the genotype-phenotype complex. Nonspeci fi c interactions with resins can be counteracted by including an excess of salmon sperm DNA, tRNA, or BSA in the buffers. Recently, it was suggested to use of polylysine "wrappers" as coatings to mask the negatively charged RNA and minimize its impact on the outcome of selections ( 75 ) ; however, this strategy has not yet been applied to in vitro evolution of enzymes. Furthermore, nonspeci fi c resin interactions can be selected against by fi rst incubating the genotype-phenotype complex with the resin alone and then using only the fl ow through for the real selection resin that is modi fi ed with the appropriate capture agents.
7. Counter selections . Alternating cycles of selection and counter selection can be used to ensure that the bond-forming or bond-breaking activity occurs at the desired site within the substrate. For example, when isolating nucleases or proteases, counter selections should be employed to improve the speci fi city of the enzyme toward a desired sequence within the recognition site. Previous work has shown that selections for bond-breaking activity without counter selection can enrich for catalysts that break bonds outside of the expected region ( 76, 77 ) . In one case, the selection for a peptidase resulted in the isolation of DNA nucleases instead ( 76 ) .
8. For small molecule substrates, the site of modi fi cation may be close to the site recognized or acted upon by an enzyme. As with any directed evolution experiment, it is important to con fi rm that the isolated enzyme also processes the unmodi fi ed substrate.
9. Spacers . Attachment of the genotype, substrate, or additional protein domains to the enzyme of interest requires suf fi cient spacing to minimize impact of these fusions on the enzyme's performance. Depending on the location of the protein termini, simple fl exible linkers composed of G n S n ( 4 ) or rigid linkers using the (EAAAAK) n motif can be used to provide appropriate spacing ( 78 ) . Similarly, polyethylene glycol spacers or alkyl chains of varied length can be used as connectors ( 3 ) .
10. The decision of whether to modify the substrate or employ product-speci fi c antibodies depends on the substrate size and antibody availability. For example, the use of productspeci fi c antibodies would be preferred for small molecule substrates where the derivatization may affect the binding to the enzyme. However, if the substrate is a large molecule, it may be simpler to derivatize the substrate (without affecting the enzyme's performance) than to generate a productspeci fi c antibody.
